Skip to main content
Log in

Early treatment cost effective in adolescents with chronic HCV

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

Reference

  • Nguyen J, et al. Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection. Journal of Pediatrics : 6 Feb 2019. Available from: URL: https://doi.org/10.1016/j.jpeds.2018.12.012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Early treatment cost effective in adolescents with chronic HCV. PharmacoEcon Outcomes News 822, 6 (2019). https://doi.org/10.1007/s40274-019-5658-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5658-3

Navigation